Section 5: Patient Safety and Quality Assurance 2021
DOI: 10.1136/ejhpharm-2021-eahpconf.298
|View full text |Cite
|
Sign up to set email alerts
|

5PSQ-179 Reason for discontinuation of biological drug treatment in rheumatoid arthritis

Abstract: Background and importance Pain is highly prevalent in old, frail adults with paracetamol as the mainstay treatment. Pain management is regularly suboptimal and using different paracetamol formulations might improve pain control.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles